Low raltegravir concentration in cerebrospinal fluid in patients with ABCG2 genetic variants

Kiyoto Tsuchiya1, Tsunefusa Hayashida, Akinobu Hamada

  • 1*AIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, Japan; †Department of Clinical Pharmacology, Group for Translational Research Support Core, National Cancer Center Research Institute, Tokyo, Japan; ‡Department of Medical Oncology and Translational Research, Kumamoto University, Kumamoto, Japan; §Department of Microbiology and Immunology, Keio University School of Medicine, Tokyo, Japan; and ‖Center for AIDS Research, Kumamoto University, Kumamoto, Japan.